|By Business Wire||
|July 22, 2014 01:44 PM EDT||
VuCOMP, Inc., leading developer of advanced computer vision systems for the detection of breast cancer, announced today that it has amended its Health Canada Medical Device License to include M-Vu Breast Density. The amendment provides clearance for VuCOMP to sell and market its M-Vu Breast Density product throughout Canada.
The clearance is timely as bill C-314, An Act Respecting the awareness of screening among women with dense breast tissue has been introduced in Canada. The act requires the Government of Canada to encourage the use of existing initiatives in order to increase awareness among women about the implications of heterogeneous or dense breast tissue for breast cancer screening, and to assist women and health care providers in making well-informed decisions regarding screening.
Jim Pike, President and CTO of VuCOMP stated, “We are pleased to now offer M-Vu Breast Density to the breast radiology community in Canada. Breast cancer is the second leading cause of death from cancer in Canadian women, with over 24,000 women diagnosed each year. We hope our M-Vu Breast Density tool will aid radiologists as they fight to lower this statistic.”
Clinical studies have shown that dense breasts can hide a cancerous lesion by reducing the ability to visualize fine structures and details that could indicate a malignant abnormality, making breast cancer detection in a mammogram more difficult. M-Vu Breast Density is designed to advance the science of breast density measurement by identifying dense tissue in the breast that could be masking cancer.
In addition to M-Vu Breast Density, clinics around the world are using the company’s M-Vu® Computer-Aided Detection (CAD) for mammography. M-Vu CAD analyzes mammograms to mark areas consistent with breast cancer using sophisticated mathematical algorithms.
About VuCOMP, Inc.
VuCOMP, Inc. leads the way in setting a new standard for CAD and automated breast density measurement. The company is dedicated exclusively to developing advanced cancer detecting technologies. VuCOMP’s engineering team has worked together since 1986, pioneering some of the world’s most advanced computer vision systems. For more information, please visit www.vucomp.com.
Data is an unusual currency; it is not restricted by the same transactional limitations as money or people. In fact, the more that you leverage your data across multiple business use cases, the more valuable it becomes to the organization. And the same can be said about the organization’s analytics. In his session at 19th Cloud Expo, Bill Schmarzo, CTO for the Big Data Practice at EMC, will introduce a methodology for capturing, enriching and sharing data (and analytics) across the organizati...
Aug. 30, 2016 09:08 AM EDT
Aug. 30, 2016 08:45 AM EDT Reads: 902
Aug. 30, 2016 05:45 AM EDT Reads: 2,459
Aug. 30, 2016 03:45 AM EDT Reads: 504
Aug. 30, 2016 02:30 AM EDT Reads: 1,860
Aug. 30, 2016 02:00 AM EDT Reads: 2,244
Aug. 30, 2016 01:30 AM EDT Reads: 3,051
Aug. 30, 2016 01:15 AM EDT Reads: 2,358
Aug. 30, 2016 01:00 AM EDT Reads: 1,940
Aug. 30, 2016 12:00 AM EDT Reads: 1,675
Aug. 29, 2016 10:00 PM EDT Reads: 2,494
Aug. 29, 2016 08:30 PM EDT Reads: 2,452
Aug. 29, 2016 08:15 PM EDT Reads: 1,880
Aug. 29, 2016 08:00 PM EDT Reads: 928
Aug. 29, 2016 07:00 PM EDT Reads: 1,988